Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Ezetimibe + Atorvastatin in Hypercholesterolemia
NCT03882996Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Oct 2000
- Primary completion
- Feb 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ezetimibe in hypercholesterolemia, heterozygous familial hypercholesterolemia (HeFH), sponsored by Organon & Co.. Started Oct 2000; status: completed.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemiaheterozygous familial hypercholesterolemia (HeFH)
Beyond the preview
Go deeper on NCT03882996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03882996.